Pharmaceuticals, Biotechnology and Life Sciences
The European Medicines Agency (EMA) has accepted for review Sanofi’s regulatory submission for oral treatment sotagliflozin, developed in partnership with…
European Medicines Agency (EMA) has accepted BioMarin’s submission of a Marketing Authorization Application (MAA) for pegvaliase for the treatment of…
Actinium Pharmaceuticals and Astellas Pharma will work together to develop Actinium-225 Radio-Conjugates (ARCs) using Actinium Warhead Enabling (AWE) Platform Technology,…
The European Commission has approved Mylan/Biocon’s co-developed biosimilar insulin glargine Semglee marketing authorization for people with diabetes after it got…
Glycotope has chosen Crown Bioscience to work together on immuno-oncology drug discovery pipeline, the subsidiary of Crown Bioscience Internation said…
Shield Therapeutics’s Feraccru can now be used as a treatment of all adults with iron deficiency (ID) as the company…
Novartis will sell its 36.5 percent stake in its consumer healthcare joint venture (JV) to GSK for $13.0 billion, it…
Vifor Pharma Group has granted Japanese company Zeria Pharmaceutical exclusive rights to develop and commercialise Veltassa, its sodium-free potassium binder approved…
Bristol-Myers Squibb said on Monday that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency…
GeNeuro’s results from the Phase 2b study of its novel therapeutic treatment of multiple sclerosis (MS) showed a significant, consistent positive…